Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07660406
PHASE1/PHASE2

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

Keloids are often described as benign dermal fibroproliferative lesions characterized by increased growth beyond the boundaries of the original wound margin.Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars. Thus this prospective study is going to investigate whether 68Ga-RGD PET/CT may provide evidence for diagnosis and evaluate the effectiveness of treatment.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-08-01

Completion Date

2027-10

Last Updated

2026-06-22

Healthy Volunteers

No

Conditions

Interventions

DRUG

68Ga-RGD

Intravenous injection of one dosage of 18.5-22.2MBq (0.5-0.6 mCi)/Kg 68Ga-FAPI. Tracer doses of 68Ga- FAPI will be used to image lesions of keloid by PET/ CT.

Locations (1)

Peking Union Medical College Hospital

Beijing, China